The revenue of Bone Biologics with headquarters in the United States amounted to **** billion U.S. dollars in 2020. The reported fiscal year ends on December 31.
The earliest shown value from 2016 exhibits a nearly identical value to 2020. The trend from 2016 to 2020 shows, furthermore, very little fluctuations in between.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
U.S. Securities and Exchange Commission. (October 24, 2024). Revenue of Bone Biologics from 2016 to 2020 (in billion U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 20, 2026, from /statistics/1528598/bone-biologics-revenue/
U.S. Securities and Exchange Commission. "Revenue of Bone Biologics from 2016 to 2020 (in billion U.S. dollars)." Chart. October 24, 2024. ÌÇÐÄÆƽâ°æ. Accessed July 20, 2026. /statistics/1528598/bone-biologics-revenue/
U.S. Securities and Exchange Commission. (2024). Revenue of Bone Biologics from 2016 to 2020 (in billion U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 20, 2026. /statistics/1528598/bone-biologics-revenue/
U.S. Securities and Exchange Commission. "Revenue of Bone Biologics from 2016 to 2020 (in Billion U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 24 Oct 2024, /statistics/1528598/bone-biologics-revenue/
U.S. Securities and Exchange Commission, Revenue of Bone Biologics from 2016 to 2020 (in billion U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1528598/bone-biologics-revenue/ (last visited July 20, 2026)
Revenue of Bone Biologics from 2016 to 2020 (in billion U.S. dollars) [Graph], U.S. Securities and Exchange Commission, October 24, 2024. [Online]. Available: /statistics/1528598/bone-biologics-revenue/
